Karyopharm Therapeutics Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | — | — | $6.5M |
| FY2012 | $29.2M | $1.3M | $391.0K |
| FY2013 | $3.3M | $158.2M | $156.0M |
| FY2014 | $13.5M | $220.3M | $150.6M |
| FY2015 | $17.1M | $215.4M | $58.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | — | — | $6.5M |
| FY2012 | $29.2M | $1.3M | $391.0K |
| FY2013 | $3.3M | $158.2M | $156.0M |
| FY2014 | $13.5M | $220.3M | $150.6M |
| FY2015 | $17.1M | $215.4M | $58.4M |